Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,945.00
-165.00 (-4.01%)
At close: Oct 10, 2025
-4.01%
Market Cap60.47B
Revenue (ttm)201.83B
Net Income (ttm)262.62M
Shares Out15.33M
EPS (ttm)17.50
PE Ratio225.41
Forward PEn/a
Dividend75.00 (1.83%)
Ex-Dividend DateDec 27, 2024
Volume77,302
Average Volume42,494
Open4,130.00
Previous Close4,110.00
Day's Range3,910.00 - 4,135.00
52-Week Range3,070.00 - 6,130.00
Beta0.59
RSI28.49
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.